Immediate Impact
2 from Science/Nature 61 standout
Citing Papers
Health Supervision for Children and Adolescents With Down Syndrome
2022 Standout
The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson’s disease
2022 Standout
Works of Jesper Mai being referenced
Epilepsy in Down syndrome--prevalence in three age groups.
1996
Glutathione peroxidase in early and advanced Parkinson's disease.
1991
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Jesper Mai | 112 | 38 | 52 | 52 | 17 | 254 | |
| Cira Antonietta Forte | 53 | 49 | 43 | 22 | 19 | 330 | |
| Kazem Ghaemi | 60 | 89 | 64 | 15 | 19 | 327 | |
| Chanda Kulkarni | 80 | 30 | 67 | 13 | 18 | 230 | |
| Amjad Samara | 19 | 18 | 21 | 38 | 26 | 310 | |
| Metab Algeffari | 48 | 37 | 20 | 13 | 18 | 317 | |
| Peipei Qin | 30 | 7 | 30 | 26 | 23 | 313 | |
| Jingkun Miao | 54 | 14 | 102 | 7 | 32 | 318 | |
| Lizhuo Li | 16 | 53 | 31 | 29 | 18 | 333 | |
| H.‐J. Gruber | 135 | 7 | 10 | 44 | 14 | 314 | |
| Sara Pompanin | 65 | 90 | 32 | 13 | 13 | 315 |
All Works
Loading papers...